Cargando…
Antiplatelet drugs in cardiological practice: Established strategies and new developments
A common pathophysiological course in vascular diseases is an overwhelming activation and aggregation of blood platelets, which results in atherothrombosis. By causing the last decisive step of cerebral, coronary, or peripheral arterial ischemia thrombotic complications of atherosclerotic disease re...
Autores principales: | Krötz, Florian, Sohn, Hae-Young, Klauss, Volker |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515423/ https://www.ncbi.nlm.nih.gov/pubmed/18827913 |
Ejemplares similares
-
Statement on Antiplatelet Agents and Anticoagulants in Cardiology -
2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019) -
Myeloperoxidase Is Not Useful for Detecting Stress Inducible Myocardial Ischemia but May Be Indicative of the Severity of Coronary Artery Disease
por: Schuhmann, Christoph G., et al.
Publicado: (2014) -
Pharmacogenetics of Antiplatelet Drugs
por: Curtin, Ronan, et al.
Publicado: (2002) -
Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
por: Jung, Jung Hwa, et al.
Publicado: (2015) -
Geriatric Cardiology: Principles and Practice
por: Pentecost, Brian
Publicado: (1994)